Yasmin generic released by Mylan
PITTSBURGH — Mylan N.V. has announced the U.S. launch of drospirenone and ethinyl estradiol tablets (3 mg/0.03 mg), an oral contraceptive. Mylan said Tuesday that the product, a generic version of Yasmin tablets from Bayer, is available immediately and represents its 13th oral contraceptive launch in the United States. Mylan’s partner Famy Care Ltd. received
